{"schema_version":"secwatch.filing_event.v1","accession":"0001420720-23-000068","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2023-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.013636+00:00","generated_at":"2026-06-07T15:30:50.421504+00:00","sec_items":["3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"iBio closes public offering of common stock and warrants, raising ~$4.5M gross proceeds","bullets":["Offering included 600K shares common stock, 1.65M pre-funded warrants, and 4.5M Series C/D warrants exercisable at $2.00.","Gross proceeds of ~$4.5M; net proceeds for working capital, R&D, trial preparation, and severance payments.","Placement agents A.G.P./Alliance Global Partners (lead) and Brookline Capital Markets receive 5.5% cash fee plus expense reimbursement.","Tail warrants issued to H.C. Wainwright for 131,820 shares at $2.50 exercise price if certain investors participate."],"urls":{"canonical":"https://secwatch.observer/filing/0001420720-23-000068","json":"https://secwatch.observer/filing/0001420720-23-000068.json","markdown":"https://secwatch.observer/filing/0001420720-23-000068.md","text":"https://secwatch.observer/filing/0001420720-23-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000142072023000068/0001420720-23-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000142072023000068/ibio-20231207x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T15:30:50.421504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}